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Abstract 
Objective: To compare Methylene blue and 
Lugol’s Iodine as6an adjunctive tool6for early 
diagnosis of premalignant oral6lesions by taking 
histopathology as gold standard. 
Methods: In this cross-sectional study patients of 
oral0premalignant lesions were selected. Methylene 
blue and lugols iodine staining was used at lesion’s 
area. Mucosa0of target site was dried gently by 
gauze0and power0air0spray with triple syringe to 
make sure that the0lesion is not0being contaminated 
with0saliva. The dye was applied directly with a 
cotton0bud for 10-20 seconds and was decolorized. 
The dye retention pattern was evaluated by stain 
retention’s intensity on the lesion. Incisional biopsy 
was performed simultaneously from that site as gold 
standard.   
Results: Out of 60 cases, males were 81.6%. 
Majority (65.0%) had more than one addicting habit 
of mainpuri, gutka and supari. The commonest 
region of oral lesions was the buccal6mucosa 
(61.6%). According to the diagnostic accuracy of 
methylene blue the sensitivity was 89.4% and 
specificity was 66.6%. According to the Lugol’s 
Iodine sensitivity was 83.3% and specificity was 
50%.  
Conclusion: Methylene blue and lugols iodine 
staining are an easy and non-invasive screening tools 
for the early diagnosis of malignancy.  
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Introduction 
Oral cavity represents nearly 3% of overall cancers. Its 
annual   incidence is approximately 0.5 million new 
cases per year.1 Despite of incredible developments in 
therapeutic modalities, the survival rate of 5-year 
hasn’t significantly enhanced over the previous many 
decades as well as yet drifts at nearly 50% to 60%.2,3 
Oral6squamous cell6carcinoma (OSCC) is placed in 8th 
level in cancer prevalence globally.3 Several OSCCs 
emerge from premalignant lesions and oral cavity 
disorders.4 Tobacco usage has been found as a 
substantial risk for6the occurrence of6OSCC and 
premalignant0lesions. Around 80% of cases with oral 
squamous cell carcinoma have utilized tobacco 
products.5 Alcohol consumption has as well been 
considered as risk factor for developing oral squamous 
cell carcinoma and premalignant0lesions. Studies have 
exhibited that heavy to moderate drinkers have 3 to 9 
fold higher risk of acquiring malignancy. Heavy 
consumption of tobacco and alcohol in combination 
can possibly carry risk 100-folds higher than the 
general populace.5 A variety of conditions are involved 
in occurrence of oral malignancy, including 
erythroplakia, oral submucous fibrosis, leukoplakia, 
palatal0lesion of reverse0cigar smoking, discoid lupus 
erythematosus, and hereditary conditions for instance 
epidermolysis bullosa and dyskeratosis congenital.7,8 
To avoid malignant metamorphosis of6these 
predecessor lesions, multiple6detection and screening 
methods have6been established.9 
 Biopsy of oral cavity with histological appraisal is a 
benchmark for oral premalignant disorders. Yet, being 
invasive, a few patients can possibly not afford this 
investigation, particularly if lesion seems “normal”.   
The outcomes can possibly be influenced by depth and 
size of biopsy, specimen quality, freezing & fixation 
methods, and experience of pathologist.10 Techniques 
of detection, which are non-invasive, are of help for 
oral premalignant disorders.  In previous few decades, 
wide-ranging non-invasive methods have emerged for 
oral premalignant disorders detection.10 
In diagnosis, Methylene Blue method’s precision is 
used to identify dysplasia, carcinoma or intestinal 
metaplasia.11 The exact process for Methylene blue’s 
uptake in epithelial tissues can possibly be similar to 
that of6Toluidine blue6in acidophilic characteristics of 
cells6with uncharacteristic concentrations of6nucleic 
acid, leading to differential uptakes amid 
benign/normal6and highly malignant/ 
dysplastic6cells. Methylene blue is frequently applied 
stain that comforts in seeing microscopic organisms in 
vivid colors. The Methylene6blue dye exhibits 
the6deepest color of6blue, representing a potential 
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temptation to6acids together with DNA.11   The 
structures of mucosal surface of oropharynx and 
mouth are much like the proximal3esophagus and 
neoplastic transformational risk factors at6these areas 
are alike. Lugol’s6iodine imaging of 
dysplastic0mucosa is used to manage esophageal 
disorder. Though, lugol's iodine staining relies upon 
the glycogen contents existing within normal 
epithelium as well as this selective characteristic of 
staining assists in outlining the carcinomatous or 
inflammatory epithelium from typical epithelium 
where content of glycogen is low.15,16   
 
Patients  and Methods 
 This descriptive study was held at outpatient 
Department Oral surgery, Isra Dental College and       
histopathological laboratory of Isra University, 
Hyderabad. Study duration was 6 months from Jan. 
2017 to July 2017. All the patients aged from 20 to 70 
years, clinical6suspicion of oral6squamous cell 
carcinoma and oral premalignant0lesion, patients with 
habits of chewing betel quid, areca nuts etc and 
patients with the habit of tobacco consumption and/or 
smoking either of gender were included. Patients were 
distributed equally in 2 groups. Lesions sites 
were6applied earlier with61% lactic acid by 
cotton6bud for220 seconds and additionally 
rinsed6with water to eliminate excess saliva and food 
debris and for providing a reliable oral setting. The 
mucosa6of targeted site was gently cleaned with 
gauze6and power air6spray with triple syringe to 
make sure that the lesions are not being infested with 
saliva. The patients of group one were underwent dye 
(1%) methylene blue directly smeared with cotton bud 
for 10 to 20 seconds and were decolorized with62% 
lactic acid with cotton6bud for220 to 30 seconds, and a 
photographs were taken.11 .The dye retention pattern 
was appraised with intensity on the6lesion. Local, 
and6deep blue stains6were exhibited as6positive (+) 
reaction,while shallow, wide, faint6blue or no 
retention was exhibited as negative (–) reaction. In 
patients of Group B  dye (1%) lugols iodine was 
directly applied6with a cotton6bud for 106to620 
seconds and was6decolorized with22% acetic acid by 
cotton6bud for 200to030 seconds, and a 
photograph6was taken. The dye retention’s pattern 
was evaluated by stain’s intensity on lesion. Dark 
brown stains were exhibited as negative (-) reaction, 
while light brown, shallow, faint or no retention of 
brown stains were exhibited as positive (+) reaction. 
The outcomes of lugol’s6iodine dye and 
Methylene6blue dye staining6were noted with photos 
and6incisional biopsies were carried out 
simultaneously for suspected lesions to evaluate 
the6diagnostic accuracy6of lugol’s6iodine. 
The6continuous variables were computed as mean and 
standard deviation. Categorical variable were 
computed as frequency and percentage. ROC-curve 
analysis was applied for  sensitivity and specificity.        
 
Results 
T     Majority of patients were in64th-5th decade6of life and 
mean age of males was 41.9±10.7 years and females 
39.8±7.74 years. Most of the cases (65%) had more than 
one habit followed by Mainpuri 8.3% (Table 1). 
According to the pre-cancerous lesions homogenous 
leukoplakia was most common (65.0%)(Table 
2).Methylene blue showed 89.4% sensitivity and 66.6% 
specificity, Lugol’s Iodine showed 83.3% sensitivity 
and 50% specificity(Figure 1-4). 
 
Table. 1: Basic information of patients (n=60) 
Variables     Frequency            % 
Age Groups  
20-290 03 05.0% 
30-390 19  31.6% 
40-490 20  33.4% 
50-590 15 25.0% 
>600 03 05.0% 
Total 60 100.0% 
Gender 
Male 48 80.0% 
Female 12 20.0% 
Total 60 100.0% 
Habits 
Mainpuri 05 08.3 % 
Ghutkha 02 03.3 % 
Betel nut 08 13.4 % 
Pan 03 05.0 % 
Smoking 03 05.0% 
More than one Habit 39 65.0% 
Total 60 100.0% 
Site involvement  
Buccal mucosa 37 61.6% 
Alveolus 10 16.6% 
Lip 05 08.4% 
Tongue 04 06.6% 
Retromolar area 02 03.4% 
Palate 01 01.6% 
Floor of mouth 01 01.6% 
Table 2. Distribution of groups according 
to precancerous lesions (n=30) 
Precancerous lesions  Frequency  % 
Homogenous leukoplakia 39 65.0% 
Speckled leukoplakia 10 16.7% 
Erosive  lichen planus 03 05.0% 
Epithelial  hyperplasia 08 13.3% 
Total 60 100.0% 
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Figure 1:Specificity and Sensitivity of (MB) in diagnosis 
of6malignant lesions by ROC curve analysis (95% CI; = 
(0.163-0.670);AUC (area under curve) = 0.417;Sensitivity:  
89.4%             Specificity:  66.6% 
 
 
Figure 2: Specificity and sensitivity of (LI) in diagnosis 
of6malignant lesions by ROC curve analysis;(95% CI; = 
(0.276-0.808);AUC (area under curve) =0.542;Sensitivity:  
83.3% ;Specificity:  50% 
 
 
Figure3. Photograph of a patient with positive lugols 
iodine staining (Printed with patient’s consent) 
 
 
Figure 4 Photo of a patient with positive methylene blue 
staining (Printed with patient’s consent) 
Discussion  
Ya-Wei Chen et al reported that the6patients’ ages 
(patient6group) varied between 31 and 82 years (410± 
150years), with6the ratio of6male to 
female6being951:7.1 In  present study when habit 
profile of study population were seen more than 
39(65%) patients had more than one habit. 5(8.3%) 
patients were used to take mainpuri while 2(3.3%) 
were in habit of eating gutka. 8(13.3%) were taking 
betel nuts and 3(5%) were using pan and were 
smokers.  Similarly Ya-Wei Chen et al reported that 
2/3rd of cases (n=38) were found with history of 
betel6quid chewing, and652 subjects had a history of 
cigarette6smoking. 1 When habit profile in male and 
females were compared than it was found that males 
were more addicted as compared to females (p=0.001).  
In majority (60%) of the patients, buccal mucosa was 
affected.In different studies it is reported that 
Leukoplakias6on the floor6of mouth, lateral6tongue, 
and lower6lip exhibit more dysplasia6or malignant 
alteration.2,3 
In this study Methylene blue showed best diagnostic 
efficacy as; sensitivity was 83.3% and specificity was 
50.0%.  Epstein6et al conducted a comparative study, 
in which lugol’s6iodine and TB were applied both in 
blend and individually in 599patients and the 
sensitivity and6specificity of Lugol’s iodine were 0.875 
and 0.842, respectively. 14 The authors established that 
Lugol’s6iodine had less6sensitivity in detecting 
oral6malignant and dysplastic6lesions however it6had 
higher specificity.  In another study, 306subjects with 
clinically6suspicious oral6PMDs and 306subjects with 
clinically6suspicious malignant6lesions were 
stained6consecutively with lugol’s iodine and TB, the 
general sensitivity to detect malignant6lesions or 
dysplasia was692.7% however the specificity was660% 
reported by Nagaraju6et al.15 Majority of the6studies 
accessed established that Lugol’s iodine could possibly 
have high potential6for oral6PMDs and6oral 
carcinomas screening. As well as in this study no 
significant difference was found between three groups 
of precancerous patients, positive reaction was found 
in 7 patients out of 10, in group 2 reaction was positive 
in 8 cases while in group 3 reaction was positive in 9 
patients out of 10.  
In this study Methylene blue showed best diagnostic 
efficacy as; sensitivity was 89.4% and specificity was 
66.6%. Nagaraju K et al stated that general sensitivity 
of Lugol's6iodine if used consecutively6with toluidine 
blue6in detecting6dysplasia or malignant6lesions 
was692.7% however specificity was660% and DA, 
NPV and PPV were 90%, 43% and 96%respectively.  
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Similarly Riaz A et al  reported that the sensitivity6of 
methylene blue6in determining6dysplastic and 
carcinomatous6changes was6determined as691.4% 
however the specificity6was determined as666.6%.21 
Other studies showed overall6sensitivity of695% 
(100% for6malignancy and692% for 
potentially6malignant lesions) was6reported, 
contrasted to the672–100% sensitivity6stated in earlier 
studies.22,23  
 
Conclusion 
1.Methylene blue and lugol`s iodine should be 
considered as a non-invasive diagnostic tools for the 
early diagnosis of premalignant and malignant lesions 
of oral cavity with high sensitivity and specificity.  
2.Early identification of these lesions is important for 
prevention and management of malignancy.  Betel 
quid and smoking habits should be avoided  
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